Astera Labs reported a 104% surge in Q2 revenue, reaching $392.4 million, with Q3 guidance projecting approximately 40% sequential growth to $550 million. The Scorpio product line is expected to surpass Aries as the company's largest, boosting semiconductor content per AI accelerator. Operating margins are forecasted to expand to around 43% in Q3, indicating strong revenue growth alongside improved operating leverage. The stock trades at a high valuation, making continued customer adoption of Scorpio crucial for sustaining its premium status through 2027.
Piper Sandler raised AbbVie's price target to $303, indicating a potential 13.92% upside from its current price of $265.97. This reflects positive expectations for the biopharmaceutical company's future performance. Institutional investors like J. M....
BTIG reaffirmed its 'Buy' rating for Glaukos and increased the price target to $202, citing strong sales growth. U.S. glaucoma sales rose 64% to $118.5 million, driven by the iDose TR product, while Corneal Health revenues grew 48% to $30.4 million, ...
Berkshire Hathaway has allocated 29.7% of its $356 billion investment portfolio to just two artificial intelligence stocks. This significant concentration underscores the growing confidence and interest in AI technologies as key drivers of future gro...
Wolfe Research has increased its price target for Fox Corporation to $93, indicating a strong positive outlook for the media company. This new target suggests a potential 54% gain from the current stock price of around $60.39, well above its 52-week ...
Autodesk, a major design software company with a market cap of about $53 billion, has seen its stock rise 15.26% over the past month, outperforming its sector and the S&P 500. Despite a recent "Neutral" rating from Citigroup and some daily price fluc...
